Sonoma Pharmaceuticals Inc (SNOA)

Healthcare | Drug Manufacturers Specialty Generic
Income Statement (Quarterly) 2025-06-30 2024-12-31 2024-09-30 2024-06-30
Revenue 4,015,000 3,564,000 3,579,000 3,391,000
Cost of Revenue 2,551,000 2,294,000 2,218,000 2,085,000
Gross Profit 1,464,000 1,270,000 1,361,000 1,306,000
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 1,965,000 1,874,000 1,705,000 2,009,000
Operating Expenses 2,559,000 2,301,000 2,211,000 2,479,000
Operating Income -1,095,000 -1,031,000 -850,000 -1,173,000
Interest Expense 0 0 0 0
Income Before Tax -1,242,000 -919,000 -463,000 -997,000
Income Tax Expense -1,000 9,000 147,000 146,000
Net Income -1,241,000 -928,000 -610,000 -1,143,000
Per Share
EPS -0.76 -0.63 -0.59 -1.34
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Revenue 14,288,000 12,735,000 13,272,000 12,628,000 18,629,000
Cost of Revenue 8,823,000 7,990,000 8,795,000 8,635,000 12,070,000
Gross Profit 5,465,000 4,745,000 4,477,000 3,993,000 6,559,000
Operating Expenses
R&D Expenses 0 0 0 0 0
SG&A Expenses 7,361,000 7,575,000 8,840,000 9,755,000 9,453,000
Operating Expenses 9,175,000 9,446,000 9,047,000 9,880,000 10,008,000
Operating Income -3,710,000 -4,701,000 -4,570,000 -5,887,000 -3,449,000
Interest Expense 0 0 16,000 -10,000 12,000
Income Before Tax -2,907,000 -5,031,000 -5,184,000 -5,418,000 -3,902,000
Income Tax Expense 550,000 -196,000 -33,000 -332,000 713,000
Net Income -3,457,000 -4,835,000 -5,151,000 -5,086,000 -3,950,000
Per Share
EPS -2.79 -5.32 -15.18 -1.92 -1.97
EPS Diluted 0.00 0.00 0.00 0.00 0.00
Balance Sheet (Quarterly) 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Assets
Cash and Cash Equivalents 5,374,000 3,128,000 3,820,000 7,396,000
Short Term Investments 0 0 0 0
Net Receivables 3,763,000 2,898,000 6,417,000 4,778,000
Inventory 2,915,000 2,719,000 2,858,000 2,663,000
Total Current Assets 12,648,000 12,548,000 13,798,000 16,430,000
Property Plant Equipment 309,000 651,000 906,000 879,000
Goodwill and Intangibles 0 0 0 0
Total Assets 13,693,000 14,740,000 16,231,000 18,845,000
Liabilities
Account Payables 953,000 607,000 841,000 1,641,000
Short Term Debt 278,000 521,000 687,000 1,058,000
Total Current Liabilities 4,096,000 3,719,000 3,717,000 5,819,000
Long Term Debt 27,000 87,000 162,000 309,000
Total Liabilities 9,282,000 8,603,000 8,254,000 10,148,000
Shareholders Equity
Retained Earnings -197,806,000 -194,349,000 -189,514,000 -184,363,000
Total Shareholders Equity 4,411,000 6,137,000 7,977,000 8,697,000
Balance Sheet (Annual) 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Assets
Cash and Cash Equivalents 5,374,000 3,128,000 3,820,000 7,396,000 4,220,000
Short Term Investments 0 0 0 0 0
Net Receivables 3,763,000 2,898,000 6,417,000 4,778,000 4,656,000
Inventory 2,915,000 2,719,000 2,858,000 2,663,000 2,530,000
Total Current Assets 12,648,000 12,548,000 13,798,000 16,430,000 12,983,000
Property Plant Equipment 309,000 651,000 906,000 879,000 1,129,000
Goodwill and Intangibles 0 0 0 0 0
Total Assets 13,693,000 14,740,000 16,231,000 18,845,000 14,987,000
Liabilities
Account Payables 953,000 607,000 841,000 1,641,000 1,769,000
Short Term Debt 278,000 521,000 687,000 1,058,000 836,000
Total Current Liabilities 4,096,000 3,719,000 3,717,000 5,819,000 4,078,000
Long Term Debt 27,000 87,000 162,000 309,000 1,839,000
Total Liabilities 9,282,000 8,603,000 8,254,000 10,148,000 9,624,000
Shareholders Equity
Retained Earnings -197,806,000 -194,349,000 -189,514,000 -184,363,000 -179,277,000
Total Shareholders Equity 4,411,000 6,137,000 7,977,000 8,697,000 5,363,000
Cash Flow Statement (Quarterly) 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Operating Activities
Net Income -3,457,000 -4,835,000 -5,151,000 -5,086,000
Depreciation & Amortization 138,000 176,000 125,000 186,000
Stock Based Compensation 224,000 516,000 669,000 382,000
Change in Working Capital 2,476,000 1,693,000 -1,864,000 3,131,000
Operating Cash Flow -88,000 -2,398,000 -6,152,000 -4,248,000
Investing Activities
Capital Expenditure -80,000 -17,000 -269,000 -137,000
Investments -80,000 -17,000 -269,000 -137,000
Investing Cash Flow -80,000 -2,000 -258,000 -99,000
Financing Activities
Debt Repayment -404,000 -481,000 -120,000 -497,000
Common Stock Issued/Repurchased 3,078,000 1,784,000 2,868,000 7,554,000
Dividends Paid 0 0 0 0
Financing Cash Flow 3,030,000 1,676,000 2,489,000 7,396,000
Summary
Free Cash Flow -168,000 -2,415,000 -6,421,000 -4,385,000
Net Change in Cash 2,246,000 -692,000 -3,576,000 3,176,000
Cash Flow Statement (Annual) 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Operating Activities
Net Income -3,457,000 -4,835,000 -5,151,000 -5,086,000 -3,950,000
Depreciation & Amortization 138,000 176,000 125,000 186,000 227,000
Stock Based Compensation 224,000 516,000 669,000 382,000 371,000
Change in Working Capital 2,476,000 1,693,000 -1,864,000 3,131,000 1,384,000
Operating Cash Flow -88,000 -2,398,000 -6,152,000 -4,248,000 -3,378,000
Investing Activities
Capital Expenditure -80,000 -17,000 -269,000 -137,000 -179,000
Investments -80,000 -17,000 -269,000 -137,000 -179,000
Investing Cash Flow -80,000 -2,000 -258,000 -99,000 388,000
Financing Activities
Debt Repayment -404,000 -481,000 -120,000 -497,000 -481,000
Common Stock Issued/Repurchased 3,078,000 1,784,000 2,868,000 7,554,000 0
Dividends Paid 0 0 0 0 0
Financing Cash Flow 3,030,000 1,676,000 2,489,000 7,396,000 3,308,000
Summary
Free Cash Flow -168,000 -2,415,000 -6,421,000 -4,385,000 -3,557,000
Net Change in Cash 2,246,000 -692,000 -3,576,000 3,176,000 529,000